These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8411700)

  • 1. [Lysosomal storage disease: a group of genetic neurodegenerative disorders].
    Suzuki Y
    Nihon Rinsho; 1993 Sep; 51(9):2264-8. PubMed ID: 8411700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene diagnosis of lysosomal diseases].
    Suzuki Y
    Nihon Rinsho; 1995 Dec; 53(12):2921-5. PubMed ID: 8577036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal storage disorders in Thailand: the Siriraj experience.
    Wasant P; Wattanaweeradej S; Raksadawan N; Kolodny EH
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():54-8. PubMed ID: 8629143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lysosomal storage diseases--an overview].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):128-32. PubMed ID: 21913413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal storage diseases: cellular pathology, clinical and genetic heterogeneity, therapy.
    Reuser AJ; Kroos MA; Visser WJ; Willemsen R
    Ann Biol Clin (Paris); 1994; 52(10):721-8. PubMed ID: 7747880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular pathology of lysosomal diseases.
    Cox TM; Cachón-González MB
    J Pathol; 2012 Jan; 226(2):241-54. PubMed ID: 21990005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stop-codon read-through for patients affected by a lysosomal storage disorder.
    Brooks DA; Muller VJ; Hopwood JJ
    Trends Mol Med; 2006 Aug; 12(8):367-73. PubMed ID: 16798086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E; Peltonen L
    Hum Mutat; 1992; 1(5):361-5. PubMed ID: 1301945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal and prenatal diagnosis of lysosomal storage diseases in the former Soviet Union.
    Krasnopolskaya XD; Mirenburg TV; Akhunov VS; Voskoboeva EY
    Wien Klin Wochenschr; 1997 Feb; 109(3):74-80. PubMed ID: 9060146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry in the study of lysosomal storage disorders.
    Meikle PJ; Fuller M; Hopwood JJ
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):769-77. PubMed ID: 14528914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse.
    Virta S; Rapola J; Jalanko A; Laine M
    J Gene Med; 2006 Jun; 8(6):699-706. PubMed ID: 16518877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic approach to the diagnosis of lysosomal storage disorders.
    Weibel TD; Brady RO
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):190-9. PubMed ID: 11553935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies.
    Kooper AJ; Janssens PM; de Groot AN; Liebrand-van Sambeek ML; van den Berg CJ; Tan-Sindhunata GB; van den Berg PP; Bijlsma EK; Smits AP; Wevers RA
    Clin Chim Acta; 2006 Sep; 371(1-2):176-82. PubMed ID: 16674934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.